0001376474-22-000299.txt : 20220624 0001376474-22-000299.hdr.sgml : 20220624 20220624110412 ACCESSION NUMBER: 0001376474-22-000299 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220624 DATE AS OF CHANGE: 20220624 EFFECTIVENESS DATE: 20220624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Viron Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001934919 IRS NUMBER: 873482047 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-450144 FILM NUMBER: 221038492 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE, STE 2631 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 781 956 9799 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE, STE 2631 CITY: BOSTON STATE: MA ZIP: 02108 D 1 primary_doc.xml X0708 D LIVE 0001934919 Viron Therapeutics Holdings, Inc. ONE BOSTON PLACE, STE 2631 BOSTON MA MASSACHUSETTS 02108 781 956 9799 DELAWARE None None Corporation true 2021 Guillermo Marmol One Boston Place Suite 2631 Boston MA MASSACHUSETTS 02108 Executive Officer Biotechnology No Revenues 06b false 2022-06-07 false true false 50000 Indefinite 305000 Indefinite false 3 0 0 0 The Chief Executive Officer, Guillermo Marmol, receives no compensation from the proceeds. false Viron Therapeutics Holdings, Inc. /s/ Guillermo Marmol Guillermo Marmol Chief Executive Officer 2022-06-23